Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Thrombocytopenia 9Leukemia, Myeloid, Acute 8Leukemia 6Leukemia, Myelomonocytic, Chronic 4Myelodysplastic Syndromes 3Leukemia, Lymphocytic, Chronic, B-Cell 3Multiple Myeloma 2Lymphoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Jacobs syndrome 2Hematologic Neoplasms 2Congenital Abnormalities 2Solid Tumor, Childhood 1Sarcoma 1Recurrence 1Purpura, Thrombocytopenic, Idiopathic 1Primary Myelofibrosis 1Pathologic Complete Response 1Osteosarcoma 1Neoplasms, Connective and Soft Tissue 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Gemcitabine 7Doxorubicin 4Cyclophosphamide 4pembrolizumab 3Magnetic Resonance Spectroscopy 3Docetaxel 3Cisplatin 3regorafenib 2Vincristine 2Tranexamic Acid 2Sunitinib 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Radiation 2Proton Therapy 2Nivolumab 2Methotrexate 2Methods 2Interviews as Topic 2Indocyanine Green 2Everolimus 2Curettage 2Ascorbic Acid 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2tocilizumab 1samarium Sm-153 lexidronam 1poly ICLC 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Bone Neoplasms × eltrombopag × Clear all
NCT01491594 2014-04-02

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Duke University

Phase 1 Terminated
1 enrolled
Sarcoma

Bone Neoplasms, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡